2. Asthma
Episodes of increased breathlessness, cough,
wheezing, chest tightness.
Exacerbations may be abrupt or progressive
Always related to decreases in expiratory (also
in inspiratory in severe cases) airflows
Hallmarks: airway inflammation, smooth
muscle constriction and mucous plugs
3. Epidemiology
Most common chronic disease in the world: varies
between regions
More prevalent in westernized countries but more severe
in developing countries
Yr of cost 2005 >$11.5 billion per year
35/100.000 fatality, mostly pre-hospital & older pop
Seasonal exacerbation pattern but ICU admission remains
constant
<10% life threatening exacerbation: 2-20% with ICU
admission; 4% intubation
Reduction in mortality (63%) in the 1980’s due to inhaled
steroids
5. Pathophysiology
Airway inflammation, smooth muscle constriction, and
airway obstruction
VQ mismatch (<0.1)- decrease vent with normal perfusion
Intrapulmonary shunt is prevented due to collateral
ventilation, hypoxic pulmonary vasoconstriction, rarely
functionally complete obstruction mild hypoxemia
Worsening of hypercapnea is indicative of impending
respiratory failure in combination of lactic acidosis
Worsening of hypoxemia after beta-agonist is common due
to removal of hypoxic induced pulmonary vasoconstriction
8. Pathophysiology
Lactic acidosis:
Changes in glycolysis due to high dose beta
agosist;
Increased wob, anaerobic metabolism
Coexisting profound tissue hypoxia
Over production of lactic acid by the lungs
Decrease lactate clearance due to hypoperfusion
9. Pathophysiology
Significantly reduced: FEV1; FEV1/FVC, Peak
expiratory flow; maximal expiratory flow at 75%,
50% and 25%, and maximal exiratory flow
between 25% and 75% of the FVC
Abnormally high airway resistance: 5-15x normal
due to shortening of airway smooth muscle,
airway edema and inflammation, excessive
luminal secretions.